MIMS – An innovative new Surgical procedure for Glaucoma

The need to avoid compliance issues associated with glaucoma topical medications is well known. The need for a safer alternative to the standard in surgical treatment of glaucoma - trabeculectomy - is clear.

Addressing both demands, Sanoculis provides a new surgical device and technique into the minimally invasive glaucoma surgery (MIGS) armamentarium.

What is MIMS?

Minimally invasive micro sclerostomy (MIMS) is an efficient, safe, fast and simple surgical technique that enables controlled fluid flow without leaving behind stitches, implants or patches. Resulting in a creation of a sclero-corneal drainage channel, the procedure ensures long-lasting controlled fluid flow with minimal complications - with the ultimate benefit of reduced intraocular pressure.

How does the procedure work?

MIMS is much less traumatic to the surrounding tissue than conventional glaucoma surgery- but what's involved? First, the surgeon creates a side port and fills the anterior chamber with a viscoelastic agent to protect the iris and prevent hypotony. Next, the sub-Tenon's is filled with the viscoelastic to create room for the rotating cutting tool protrusion. After inserting the surgical instrument through the side port to the angle (ab-interno), the surgeon presses the MIMS foot pedal and a rotating cutting tool creates the drainage channel, and withdraws automatically

along with the cylinder of sclero-corneal tissue that has been removed. The intraocular fluid drains from the anterior chamber into the subconjunctival space, where it is reabsorbed into the surrounding blood vessels.

 

 

How much time is required to complete the procedure?

The surgery is super-efficient; it takes 2-3 minutes and can be carried out in outpatient clean-room clinics, minimizing operating­room time, shortening the hospitalisation period, and saving overall costs. Due to its simplicity, the procedure can be performed by a wide range of ophthalmologists -and can be easily combined with cataract surgery, resulting in further time and cost savings.

What components are included with the device?

The MIMS device consists of a disposable surgical instrument and multi-use controller, which is designed to activate the instrument, removing the tissue with a rotary motion. The activation component comprises a footswitch and controller unit with a graphic user interface, an autoclavable motor and hose, and a stand.

 

 

How does this benefit the patient and clinician?

As MIMS is stent-less and leaves nothing behind, it not only lowers the risk of post-surgical complications but also keeps future therapeutic options very much in play for patients.

  • Lower risk of complications
  • Cost-effective
  • Simple and very quick to use
  • Avoids the need for medication
  • Suitable for most Glaucoma patients
  • Easily combined with Cataract surgery

Thanks to all these benefits, MIMS has the potential to become a new paradigm for first-line filtering surgery in glaucoma.

For more information, please contact us on:

Phone: 02920 767 800

Email: info@eakinsurgical.com

Web: www.eakinsurgical.co.uk

 

See more about Eakin Surgical Ltd

Latest Issues

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

EBME Expo

Coventry Building Society Arena
26th - 27th June 2024

The AfPP Roadshow - Cardiff

TBA, Cardiff
13th July 2024

AfPP Annual Conference 2024

University of Warwick
2nd - 3rd August 2024

The Operating Theatres North Show 2024

Etihad Stadium, Manchester
12th September 2024

The AfPP Roadshow - London

Cavendish Conference Centre, London
14th September 2024